A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization.
Saved in:
| Title: | A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization. |
|---|---|
| Authors: | Liu, Chang1 westchina_lc@foxmail.com, Li, Lei1 85536819@qq.com, Lu, Wu-sheng1 lcnolan@qq.com, Du, Hua1 duhua3983@163.com, Yan, Lu-nan1 yanlunan688@163.com, Wen, Tian-fu1 tianfu1962@163.com, Wei, Wu-ran2 jitamao55@163.com, Jiang, Li1 jl339@126.com, Xu, Ming-qing1 qlm66220@163.com |
| Source: | BMC Cancer. 2/21/2018, Vol. 18, p1-1. 1p. 4 Charts, 3 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-018-4121-3 |
